Literature DB >> 2450319

Degradation of substance P by membrane peptidases in the rat substantia nigra: effect of selective inhibitors.

A Oblin1, M J Danse, B Zivkovic.   

Abstract

The hydrolysis of substance P by membrane peptidases prepared from the rat substantia nigra was studied in the presence of selective inhibitors. Substance P degradation by synaptic and mitochondrial membranes was completely inhibited by 1,10-phenanthroline (1 mM), a non-specific metallopeptidase inhibitor. Captopril and bestatine, selective inhibitors of angiotensin converting enzyme and aminopeptidases respectively, were without effects. However, phosphoramidon (1 microM), a putative 'enkephalinase' inhibitor, selectively inhibited substance P degradation by synaptic membranes. These results suggest that a phosphoramidon-sensitive endopeptidase may be the principal enzyme responsible for substance P degradation in substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450319     DOI: 10.1016/0304-3940(88)90343-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Immunohistochemistry of the guinea-pig trachea using an anti-idiotypic antibody recognizing substance P receptors.

Authors:  W Kummer; A Fischer; U Preissler; J Y Couraud; C Heym
Journal:  Histochemistry       Date:  1990

2.  Tachykininergic synaptic transmission in the coeliac ganglion of the guinea-pig.

Authors:  F Y Zhao; K Saito; K Yoshioka; J Z Guo; T Murakoshi; S Konishi; M Otsuka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Substance P analogs displace sigma binding differentially in the brain and spinal cord of the adult mouse.

Authors:  D D Mousseau; A A Larson
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

4.  Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord.

Authors:  H Suzuki; K Yoshioka; M Yanagisawa; O Urayama; T Kurihara; R Hosoki; K Saito; M Otsuka
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

5.  The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.

Authors:  Ashley J Porter; Katharine Pillidge; Ewelina M Grabowska; S Clare Stanford
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.